-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Systemic sclerosis (SSc), also called scleroderma, can affect the gastrointestinal tract from the mouth to the colon. The esophagus is one of the most frequently involved organs, and impaired movement may develop even when skin or other organ symptoms appear limited. Recognizing esophageal involvement early helps clinicians address nutrition, reflux injury, aspiration risk, and declining quality of life.
The condition reflects a combination of smooth-muscle atrophy, vascular injury, fibrosis, and damage to the enteric nervous system. These changes can weaken peristalsis and reduce lower esophageal sphincter pressure. As a result, food and liquid may move slowly while stomach contents can flow backward into the esophagus.
Scientific congresses focused on esophageal disease, including educational programs associated with ISDE 2021, have emphasized the value of coordinated assessment. Rheumatologists, gastroenterologists, surgeons, speech and swallowing specialists, and dietitians may all contribute to effective care.
Early vascular and neural changes may interfere with coordinated contractions. Over time, smooth-muscle replacement by fibrotic tissue can produce weak or absent peristalsis. The lower esophageal sphincter may also become hypotensive, allowing acid and bile reflux to occur more easily.
The severity of gastrointestinal disease does not always match the extent of skin thickening or other systemic findings. Some patients have substantial esophageal dysfunction with few symptoms, while others report severe heartburn, regurgitation, or swallowing difficulty. Routine clinical attention is therefore important even when complaints seem mild.
Heartburn and acid regurgitation are frequent manifestations. Patients may describe a sour taste, chest discomfort after meals, nighttime coughing, or symptoms that worsen when lying down. Dysphagia can involve solids, liquids, or both, depending on the underlying motility pattern and the presence of narrowing.
Poor clearance of refluxate can expose the esophageal lining to prolonged acid contact. Complications may include erosive esophagitis, peptic strictures, Barrett’s esophagus, and, in some cases, aspiration-related respiratory problems. Bloating, early satiety, weight loss, and malnutrition may point to broader gastrointestinal involvement.
Upper endoscopy evaluates mucosal injury, strictures, rings, infection, and Barrett’s-related changes. It can also help exclude mechanical obstruction when a patient reports progressive dysphagia. A normal endoscopic appearance, however, does not rule out a movement disorder.
High-resolution esophageal manometry is central to physiologic assessment. Typical findings may include absent or weak distal contractions and reduced lower esophageal sphincter pressure. Ambulatory pH or impedance monitoring can quantify acid and non-acid reflux, especially when symptoms persist despite treatment. Barium esophagram and timed contrast studies may add information about transit and structural narrowing.
Esophageal dysfunction in SSc often progresses gradually, but patterns vary. Some patients retain partial contractile activity, whereas others develop severe hypomotility or an aperistaltic esophagus. Reflux may dominate the clinical picture even before swallowing problems become obvious.
| Feature | Predominant reflux pattern | Hypomotility pattern | Advanced clearance failure |
|---|---|---|---|
| Main physiologic change | Low sphincter pressure | Weak peristaltic contractions | Minimal or absent propulsion |
| Typical symptoms | Heartburn, regurgitation | Intermittent dysphagia, chest discomfort | Dysphagia, food retention, weight loss |
| Useful tests | Endoscopy, pH monitoring | High-resolution manometry | Manometry, timed barium study |
| Important risks | Esophagitis, Barrett’s esophagus | Reflux with poor clearance | Stricture, aspiration, malnutrition |
| Treatment focus | Reflux suppression and positioning | Reflux control and meal modification | Specialist care, nutrition, complication management |
Treatment is individualized according to symptoms, test results, mucosal damage, nutritional status, and other organ involvement. Proton pump inhibitors are commonly used for clinically significant gastroesophageal reflux, while H2-receptor antagonists may have a role in selected patients. Medication timing and adherence should be reviewed before labeling reflux as treatment-resistant.
Lifestyle measures can support symptom control. Smaller meals, careful chewing, remaining upright after eating, elevating the head of the bed, and avoiding personal trigger foods may reduce reflux exposure. Tobacco, alcohol, late meals, and medicines that irritate the esophagus should be reviewed with a clinician.
Prokinetic therapy may be considered in selected cases, although benefits and adverse effects vary. Endoscopic dilation can treat a clinically important stricture. Surgery requires particular caution because severe dysmotility may worsen postoperative swallowing or reflux; decisions should be made by an experienced multidisciplinary team.
Ongoing review is useful because esophageal disease can evolve and symptoms may be misleading. Care should address swallowing, reflux control, respiratory symptoms, body weight, anemia, and dietary intake rather than focusing on a single test result.
Patients should receive clear instructions about alarm symptoms and when to seek prompt evaluation. New or progressive dysphagia, vomiting, gastrointestinal bleeding, unintentional weight loss, persistent chest pain, or recurrent nighttime coughing deserves medical assessment.
Practical priorities include:
Esophageal involvement is a major part of gastrointestinal care in systemic sclerosis, but it can be managed more effectively when detected before complications become advanced. Educational resources and scientific discussions from the International Society for Diseases of the Esophagus can help clinicians stay informed about evolving diagnostic methods and treatment strategies. Explore the ISDE 2021 congress materials and related esophageal disease research to deepen understanding of motility disorders and multidisciplinary care.